key: cord-0971004-yk7wmq5q
authors: Tang, Xiaohan; He, Binbin; Liu, Zhenqi; Zhou, Zhiguang; Li, Xia
title: Fulminant type 1 diabetes after COVID-19 vaccination
date: 2022-01-25
journal: Diabetes Metab
DOI: 10.1016/j.diabet.2022.101324
sha: f3be3935479c08bf828369e1253f0ee500bbe729
doc_id: 971004
cord_uid: yk7wmq5q

nan

To the editor,

The ongoing pandemic of COVID-19 has led to an unprecedented acceleration of anti-COVID-19 vaccine development. Here we report the first case of fulminant type 1 diabetes mellitus (FT1DM) with complete and irreversible islet destruction after vaccination with a COVID-19 inactivated vaccine (CoronaVac ® ).

A 50-year-old male (body mass index 18·1 kg/m 2 ) presented to a local hospital due to abrupt onset of polydipsia and polyuria for one day. Six days ago, he received the first dose of a COVID-19 vaccine and developed a fever over 38.5 o C for five days after vaccination. At presentation, physical examination was normal and laboratory findings showed hyperglycemia, ketosis, metabolic acidosis, and a near normal hemoglobin A1c (HbA1c). He was diagnosed with diabetes and diabetic ketoacidosis (DKA) and was treated with fluid resuscitation and intravenous insulin infusion. DKA was resolved promptly and he was placed on a subcutaneous insulin regimen for glycemic control. He was in good health previously and not on any medication. His 75-year-old mother has type 2 diabetes mellitus. There is no family history of T1DM.

Two weeks after initial presentation, his serum ketone bodies became negative.

Further laboratory tests showed slightly elevated pancreatic enzymes, elevated HbA1c, normal lipids, slightly increased glycated serum protein, undetectable/low serum Cases with FT1DM due to immune-related factors such as drugs [2] and virus infection [3] have been reported. A recent study also showed that T-cell autoimmunity may be involved in FT1DM [4] . However, no islet-associated autoantibodies were detected in this patient. It is likely that this patient did not have sufficient time to develop islet-associated antibodies given the sudden onset of the disease. Interestingly, 4 a case of FT1DM after influenza vaccination was reported several years ago [5] .

Whether these two cases share a similar underlying mechanism is unknown and deserves further research.

Overall, this case reminds clinicians to be vigilant for the possibility of FT1DM associated with COVID-19 vaccination, particularly in patients with genetic susceptibility. 

Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus

Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy

Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report

Distinct Phenotypes of Islet Antigen-Specific CD4+ T Cells Among the 3

Subtypes of Type 1 Diabetes

Development of fulminant Type 1 diabetes with thrombocytopenia after influenza vaccination: a case report